SS
BBIO icon

Steve Schonfeld’s BridgeBio Pharma BBIO Stock Holding History

Steve Schonfeld’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$995K Buy
+13,355
New +$935K ﹤0.01% 1484
2025
Q3 		– Sell
-14,530
Closed -$627K – 2208
2025
Q2 		$627K Buy
+14,530
New +$528K ﹤0.01% 1474
2024
Q4 		– Sell
-67,831
Closed -$1.73M – 2012
2024
Q3 		$1.73M Buy
67,831
+32,450
+92% +$852K 0.01% 946
2024
Q2 		$896K Buy
+35,381
New +$967K 0.01% 1252
2024
Q1 		– Sell
-125,939
Closed -$5.08M – 2068
2023
Q4 		$5.08M Sell
125,939
-41,180
-25% -$1.24M 0.03% 511
2023
Q3 		$4.41M Buy
+167,119
New +$4.74M 0.03% 585
2023
Q2 		– Sell
-18,579
Closed -$308K – 2136
2023
Q1 		$308K Buy
+18,579
New +$217K ﹤0.01% 1370
2022
Q4 		– Sell
-97,519
Closed -$970K – 2593
2022
Q3 		$970K Sell
97,519
-79,507
-45% -$826K 0.01% 1287
2022
Q2 		$1.61M Sell
177,026
-39,274
-18% -$328K 0.02% 818
2022
Q1 		$2.19M Buy
216,300
+153,400
+244% +$1.57M 0.02% 698
2021
Q4 		$1.05M Buy
62,900
+44,700
+246% +$1.89M 0.01% 915
2021
Q3 		$853K Sell
18,200
-28,687
-61% -$1.54M 0.01% 1019
2021
Q2 		$2.86M Buy
46,887
+1,750
+4% +$99.9K 0.03% 611
2021
Q1 		$2.78M Buy
45,137
+36,211
+406% +$2.37M 0.03% 588
2020
Q4 		$635K Sell
8,926
-14,815
-62% -$715K 0.01% 961
2020
Q3 		$890K Buy
23,741
+10,395
+78% +$327K 0.02% 729
2020
Q2 		$436K Buy
+13,346
New +$407K 0.01% 858

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Steve Schonfeld's BBIO Position: Q2 2026 in Review

Steve Schonfeld opened a new position in BridgeBio Pharma (BBIO) in Q2 2026: 13,355 shares worth $995K. The stake represents ﹤0.01% of the portfolio and ranks #1484 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in BBIO as recently as Q2 2025.

Steve Schonfeld first reported a position in BBIO in Q2 2020 and has held it in 17 quarters since. The position peaked at $5.08M in Q4 2023. 471 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Steve Schonfeld held 13,355 shares of BridgeBio Pharma worth $995K as of Q2 2026.
  • BridgeBio Pharma was a new Steve Schonfeld position in Q2 2026.
  • BridgeBio Pharma made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1484 holding.
  • Steve Schonfeld first reported a position in BridgeBio Pharma in Q2 2020 and has held it in 17 quarters since.
  • Steve Schonfeld's BridgeBio Pharma position peaked at $5.08M in Q4 2023.
  • 471 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.